Crystalline compound 6-((S) -1-(6-(1-methyl-1H-pyrazole-4-IL) -[1,2,4] triazole [3,4-B] [1,3,4] diazole-3-IL) ethyl) quinoline, protein napropyl formate inhibitor； pharmacological synthesis； and methods for treating or reducing the severity of diffusive disorders, such as cancer metabolizing colon, MA Among other things, there are Ma and Hepatic.

• 收藏
• 分享

专利权人:

VERTEX PHARMACEUTICALS INCORPORATED.

发明人:

LAUFFER DAVID,LI PAN,SHANNON DEAN,LIANG JIANGLIN.

申请号：

CL2011001152

公开号：

CL2011001152A1

申请日:

2011.05.18

申请国别(地区):

CL

年份:

2012

代理人:

摘要：

Crystalline Compound 6 - ((S) - 1 - (4 - (1 - methyl - 1h-pyrazol-4-yl) - [1,2,4] triazolo [3,4-b] [1,3,4] thiadiazole - 3 - il) ethyl) quinolineInhibitor of protein kinase C - met； Pharmaceutical Composition and Method for treating or reducing the severity of a proliferative disorder as metastatic cancer of the colon, Breast and liverAmong others.Compuesto cristalino 6-((s)-1-(6-(1-metil-1h-pirazol-4-il)-[1,2,4]triazolo[3,4-b][1,3,4]tiadiazol-3-il)etil)quinolina, inhibidor de la proteina kinasa c-met； composición farmacéutica； y método para tratar o disminuir la gravedad de un trastorno proliferativo tal como cáncer metastásico de colon, mama y hepático, entre otros.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/